your limit has been reached. plz Donate us to allow your ip full access, Email: sshnevis@outlook.com

Management of cutaneous immune-related adverse events from immune checkpoint inhibitor therapy

OTC: over the counter; ICI: immune checkpoint inhibitor; GABA: gamma-aminobutyric acid; NBUVB: narrowband ultraviolet B; IL: interleukin; TNF: tumor necrosis factor.

From: Phillips GS, Wu J, Hellmann MD, et al. Treatment Outcomes of Immune-Related Cutaneous Adverse Events. J Clin Oncol 2019; 37:2746. DOI: 10.1200/JCO.18.02141. Copyright © 2019 American Society of Clinical Oncology. Reproduced with permission from Wolters Kluwer Health. Unauthorized reproduction of this material is prohibited.

Graphic 134200 Version 1.0